These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14399203)

  • 21. Action of horse urinary kallikrein on synthetic derivatives of bradykinin.
    Babel I; Stella RC; Prado ES
    Biochem Pharmacol; 1968 Oct; 17(10):2232-4. PubMed ID: 5748672
    [No Abstract]   [Full Text] [Related]  

  • 22. Isolation and amino acid composition of bradykinin released by venom of Bothrops jararaca from bovine plasma.
    HAMBERG U; BUMPUS FM; PAGE IH
    Biochim Biophys Acta; 1961 Sep; 52():533-45. PubMed ID: 13904059
    [No Abstract]   [Full Text] [Related]  

  • 23. [PATHOPHYSIOLOGY AND DIAGNOSIS OF ACUTE PANCREATITIS AND ITS SEQUELAE].
    NEUMAYR A; PESCHL L
    Klin Med Osterr Z Wiss Prakt Med; 1963 Nov; 18():541-7. PubMed ID: 14122703
    [No Abstract]   [Full Text] [Related]  

  • 24. [Activation of proteinases specifically effective against cancer protein from human urine and serum by Trasylol in the modified Abderhalden reaction (mod. A. R.)].
    TETZNER E
    Krebsarzt; 1962 Mar; 17():110-2. PubMed ID: 13920453
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of the bradykinin releasing enzyme in the venom of Agkistrodon halys blomhoffii as salivary kallikrein of the snake.
    Iwanaga S; Suzuki T
    Hoppe Seylers Z Physiol Chem; 1968 Jul; 349(7):928-9. PubMed ID: 5303673
    [No Abstract]   [Full Text] [Related]  

  • 26. Bradykininogen and bradykinin in the cardiovascular shock produced by proteolytic enzymes.
    Corrado AP; Reis ML; Carvalho IF; Diniz CR
    Biochem Pharmacol; 1966 Jul; 15(7):959-70. PubMed ID: 5967907
    [No Abstract]   [Full Text] [Related]  

  • 27. [Relationship between proteolytic and coagulative activity and bradykinin liberation by snake venoms].
    HOLTZ P; RAUDONAT HW
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 229(2):113-22. PubMed ID: 13387768
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of the acid poteinase activity of human cerebrospinal fluid].
    Kerekes M; Kovács A; Becuş T
    Stud Cercet Neurol; 1970; 15(2):77-83. PubMed ID: 5456337
    [No Abstract]   [Full Text] [Related]  

  • 29. [On an inhibitory body for kallikrein and various proteinases from cattle liver. II].
    WERLE E; APPEL W
    Z Naturforsch B; 1959 Jun; 14B():385-92. PubMed ID: 13855345
    [No Abstract]   [Full Text] [Related]  

  • 30. Proteinases in human cerebrospinal fluid.
    Riekkinen PJ; Rinne UK
    J Neurol Sci; 1968; 7(1):97-106. PubMed ID: 5696309
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of tyrosinase preparations on oxytocin, vasopressin and bradykinin.
    BISSET GW
    Br J Pharmacol Chemother; 1962 Apr; 18(2):405-20. PubMed ID: 13869528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 1: Cerebral exposure to bradykinin and plasma.
    Unterberg A; Baethmann AJ
    J Neurosurg; 1984 Jul; 61(1):87-96. PubMed ID: 6563062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kallikrein-like esterase and peptidase activities in CSF during migraine attacks and free intervals.
    Kangasniemi P; Riekkinen P; Rinne UK
    Headache; 1972 Jul; 12(2):66-8. PubMed ID: 5056181
    [No Abstract]   [Full Text] [Related]  

  • 34. ENDOGENEOUS MECHANISMS IN INCREASED VASCULAR PERMEABILITY IN INFLAMMATION.
    HAYASHI H
    Acta Pathol Jpn; 1963 Oct; 13():213-5. PubMed ID: 14195178
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipopolysaccharide activates the kallikrein-kinin system in mouse choroid plexus cell line ECPC4.
    Takano M; Satoh C; Kunimatsu N; Otani M; Hamada-Kanazawa M; Miyake M; Ming K; Yayama K; Okamoto H
    Neurosci Lett; 2008 Apr; 434(3):310-4. PubMed ID: 18329172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bradykinin half-life in subarachnoid spaces in rats].
    Damas J
    C R Seances Soc Biol Fil; 1972; 166(4):740-4. PubMed ID: 4651609
    [No Abstract]   [Full Text] [Related]  

  • 37. THE RELEASE OF VASCULAR PERMEABILITY FACTORS BY HOMOLOGOUS ANTIGEN AND BY SOLUBLE ANTIGEN-ANTIBODY COMPLEXES IN TISSUE CULTURE AND ITS BIOLOGIC SIGNIFICANCE.
    HAYASHI H; KINUWAKI Y; KOONO M; TAKABA Y
    Lab Invest; 1964 Sep; 13():1124-38. PubMed ID: 14207887
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of mK1, a true tissue (glandular) kallikrein of mouse submandibular gland: tissue distribution and a comparison of kinin-releasing activity with other submandibular kallikreins.
    Hosoi K; Tsunasawa S; Kurihara K; Aoyama H; Ueha T; Murai T; Sakiyama F
    J Biochem; 1994 Jan; 115(1):137-43. PubMed ID: 8188620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of porcine follipsin as plasma kallikrein, and its possible involvement in the production of bradykinin within the follicles of porcine ovaries.
    Kimura A; Kihara T; Okimura H; Hamabata T; Ohnishi J; Moriyama A; Takahashi K; Takahashi T
    Mol Reprod Dev; 2000 Sep; 57(1):79-87. PubMed ID: 10954859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
    El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
    Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.